Back to Search Start Over

Addressing vaccine hesitancy in developing countries: Survey and experimental evidence.

Authors :
Hoy C
Wood T
Moscoe E
Source :
PloS one [PLoS One] 2022 Nov 17; Vol. 17 (11), pp. e0277493. Date of Electronic Publication: 2022 Nov 17 (Print Publication: 2022).
Publication Year :
2022

Abstract

Vaccine hesitancy is proving to be a significant impediment to COVID-19 vaccination campaigns in some developing countries. This study focuses on vaccine hesitancy and means of reducing it. Data come from a large, representative phone survey and online randomized survey experiment, both run in Papua New Guinea, a developing country with low vaccination rates. Less than 20% of relevant respondents to the phone survey were willing to be vaccinated, primarily because of fear of side effects and low trust in the vaccine. Although vaccine hesitancy was high in the online experiment, participants who received a message emphasizing that the vaccine was safe and COVID-19 dangerous were 68% more likely to state they planned to be vaccinated than those in the control group. A message appealing to social norms was also effective in reducing vaccine hesitancy, although its efficacy was limited to certain types of people.<br />Competing Interests: The authors have declared that no competing interests exist.<br /> (Copyright: © 2022 Hoy et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)

Details

Language :
English
ISSN :
1932-6203
Volume :
17
Issue :
11
Database :
MEDLINE
Journal :
PloS one
Publication Type :
Academic Journal
Accession number :
36395260
Full Text :
https://doi.org/10.1371/journal.pone.0277493